Literature DB >> 10053121

Uterine malignant leiomyoblastoma (epithelioid leiomyosarcoma) during pregnancy.

R L Bekkers1, L F Massuger, P P Berg, U G Haelst, J Bulten.   

Abstract

A case of uterine malignant leiomyoblastoma (UML) which was initially mistaken for uterine leiomyoma on two different occasions is presented. About 20 cases of uterine leiomyoblastoma taking a malignant course have been described in the literature. This case of UML is the first diagnosed during pregnancy. In retrospect, tumor tissue removed from the uterus 4 years earlier already showed histological signs of UML. The large and metastatic tumor showed nuclear atypia, a moderate mitotic index, and tumor cell necrosis, indicating malignancy. Treatment consisted of hysterectomy, bilateral salpingo-oophorectomy, and debulking of most other tumor masses. In the literature, radio- and chemotherapy have not proved to be effective in these tumors. Hormonal therapy has only been used in 2 patients. In this patient, hormonal influence on tumor growth may be substantial. The tumor was progesterone- and estrogen-receptor positive and increased in size rapidly during pregnancy. Since little is known about these tumors further studies are necessary to evaluate hormonal influences both as a causative factor and as a therapeutic possibility. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10053121     DOI: 10.1006/gyno.1998.5289

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Metastatic uterine leiomyosarcoma at 26 weeks gestation.

Authors:  Naomi Eastwood-Wilshere; Jessica Turner; Niara Oliveira; Adam Morton
Journal:  BMJ Case Rep       Date:  2019-08-04

Review 2.  Bone and soft tissue sarcomas during pregnancy: A narrative review of the literature.

Authors:  George Zarkavelis; Dimitrios Petrakis; George Fotopoulos; Sotirios Mitrou; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2016-02-02       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.